Skip to main content
Equibles

CSS LLC/IL

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1103646 CHICAGO, IL
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$375,434
+$65,326 QoQ
Shares Held
110,422
+78.4% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#3
of 31 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CSS LLC/IL holds $23,787,576 across 16 Biotechnology names. LSTA ranks #9 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 152,289 $12,074,994
2 JAZZ
Jazz Pharmaceuticals plc
 29,041 $6,998,009
3 BMRN
Biomarin Pharmaceutical Inc
 22,580 $1,292,027
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,820 $1,134,842
5 HALO
Halozyme Therapeutics, Inc.
 6,520 $510,320
6 TVTX
Travere Therapeutics, Inc.
 8,470 $481,180
7 EXEL
Exelixis, Inc.
 8,709 $473,856
8 INCY
Incyte Corp
 3,856 $437,116

All Filings in LSTA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $375,434 110,422
2026-03-31 $310,108 61,898